Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126650042 | 12665004 | 2 | F | 20160823 | 20160818 | 20160829 | EXP | GB-MYLANLABS-2016M1033826 | MYLAN | 0.00 | Y | 0.00000 | 20160829 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126650042 | 12665004 | 1 | PS | ANASTROZOLE. | ANASTROZOLE | 1 | UNK | Y | U | 91051 | |||||||||
| 126650042 | 12665004 | 2 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | UNK | Y | U | 91051 | |||||||||
| 126650042 | 12665004 | 3 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | UNK (8 WEEK) | Y | U | 91051 | |||||||||
| 126650042 | 12665004 | 4 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | UNK (4 WEEK) | Y | U | 91051 | |||||||||
| 126650042 | 12665004 | 5 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | UNK (8 WEEK) | Y | U | 91051 | |||||||||
| 126650042 | 12665004 | 6 | SS | ANASTROZOLE ACCORD | ANASTROZOLE | 1 | UNK | Y | U | 0 | |||||||||
| 126650042 | 12665004 | 7 | SS | ARIMIDEX | ANASTROZOLE | 1 | UNK | Y | U | 0 | |||||||||
| 126650042 | 12665004 | 8 | C | OMEPRAZOLE /00661202/ | 2 | UNK (FEW MONTHS) | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126650042 | 12665004 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126650042 | 12665004 | Abasia | |
| 126650042 | 12665004 | Adverse drug reaction | |
| 126650042 | 12665004 | Anxiety | |
| 126650042 | 12665004 | Confusional state | |
| 126650042 | 12665004 | Disability | |
| 126650042 | 12665004 | Discomfort | |
| 126650042 | 12665004 | Drug hypersensitivity | |
| 126650042 | 12665004 | Drug intolerance | |
| 126650042 | 12665004 | Drug level increased | |
| 126650042 | 12665004 | Emotional distress | |
| 126650042 | 12665004 | Fear | |
| 126650042 | 12665004 | Hernia | |
| 126650042 | 12665004 | Lip swelling | |
| 126650042 | 12665004 | Menopausal symptoms | |
| 126650042 | 12665004 | Mental disorder | |
| 126650042 | 12665004 | Movement disorder | |
| 126650042 | 12665004 | Muscle disorder | |
| 126650042 | 12665004 | Muscle tightness | |
| 126650042 | 12665004 | Overdose | |
| 126650042 | 12665004 | Paraesthesia oral | |
| 126650042 | 12665004 | Product substitution issue | |
| 126650042 | 12665004 | Speech disorder | |
| 126650042 | 12665004 | Stress | |
| 126650042 | 12665004 | Swollen tongue | |
| 126650042 | 12665004 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126650042 | 12665004 | 1 | 2012 | 2013 | 0 | |
| 126650042 | 12665004 | 2 | 201305 | 201402 | 0 | |
| 126650042 | 12665004 | 6 | 201305 | 201305 | 0 | |
| 126650042 | 12665004 | 8 | 2012 | 2013 | 0 |